{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T17:00:05Z","timestamp":1778864405567,"version":"3.51.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM149252"],"award-info":[{"award-number":["R35GM149252"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01GM127652"],"award-info":[{"award-number":["R01GM127652"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"U.S. Department of Health & Human Services | NIH | National Eye Institute","doi-asserted-by":"publisher","award":["R24EY028758"],"award-info":[{"award-number":["R24EY028758"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006984","name":"Irma T. Hirschl Trust","doi-asserted-by":"publisher","award":["CU20-4313"],"award-info":[{"award-number":["CU20-4313"]}],"id":[{"id":"10.13039\/100006984","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["CU22-1892"],"award-info":[{"award-number":["CU22-1892"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-54938-z","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T16:11:35Z","timestamp":1735575095000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Neurotransmitter-bound bestrophin channel structures reveal small molecule drug targeting sites for disease treatment"],"prefix":"10.1038","volume":"15","author":[{"given":"Aaron P.","family":"Owji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyun","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8140-9267","authenticated-orcid":false,"given":"Alec","family":"Kittredge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9520-8140","authenticated-orcid":false,"given":"Jiali","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6525-2458","authenticated-orcid":false,"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5220-588X","authenticated-orcid":false,"given":"Tingting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,30]]},"reference":[{"key":"54938_CR1","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1080\/19336950.2021.1981625","volume":"15","author":"AP Owji","year":"2021","unstructured":"Owji, A. P., Kittredge, A., Zhang, Y. & Yang, T. Structure and Function of the Bestrophin family of calcium-activated chloride channels. Channels (Austin) 15, 604\u2013623 (2021).","journal-title":"Channels (Austin)"},{"key":"54938_CR2","doi-asserted-by":"publisher","unstructured":"Johnson, A. A. et al. Bestrophin 1 and retinal disease. Prog. Retin. Eye Res. https:\/\/doi.org\/10.1016\/j.preteyeres.2017.01.006 (2017).","DOI":"10.1016\/j.preteyeres.2017.01.006"},{"key":"54938_CR3","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/915","volume":"19","author":"K Petrukhin","year":"1998","unstructured":"Petrukhin, K. et al. Identification of the gene responsible for Best macular dystrophy. Nat. Genet. 19, 241\u2013247 (1998).","journal-title":"Nat. Genet."},{"key":"54938_CR4","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1038\/mt.2015.177","volume":"23","author":"T Yang","year":"2015","unstructured":"Yang, T., Justus, S., Li, Y. & Tsang, S. H. BEST1: the best target for gene and cell therapies. Mol. Ther. J. Am. Soc. Gene Ther. 23, 1805\u20131809 (2015).","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"54938_CR5","doi-asserted-by":"crossref","unstructured":"Bakall, B. et al. Bestrophin-2 is involved in the generation of intraocular pressure. Investig. Ophthalmol. Vis. Sci. 49, 1563\u20131570 (2008).","DOI":"10.1167\/iovs.07-1338"},{"key":"54938_CR6","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1167\/iovs.08-2501","volume":"50","author":"Y Zhang","year":"2009","unstructured":"Zhang, Y. et al. Enhanced inflow and outflow rates despite lower IOP in bestrophin-2-deficient mice. Investig. Ophthalmol. Vis. Sci. 50, 765\u2013770 (2009).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"54938_CR7","first-page":"200","volume":"16","author":"Y Zhang","year":"2010","unstructured":"Zhang, Y., Patil, R. V. & Marmorstein, A. D. Bestrophin 2 is expressed in human non-pigmented ciliary epithelium but not retinal pigment epithelium. Mol. Vis. 16, 200\u2013206 (2010).","journal-title":"Mol. Vis."},{"key":"54938_CR8","doi-asserted-by":"publisher","first-page":"4008","DOI":"10.1073\/pnas.052692999","volume":"99","author":"H Sun","year":"2002","unstructured":"Sun, H., Tsunenari, T., Yau, K. W. & Nathans, J. The vitelliform macular dystrophy protein defines a new family of chloride channels. Proc. Natl. Acad. Sci. USA 99, 4008\u20134013 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"54938_CR9","doi-asserted-by":"publisher","first-page":"41114","DOI":"10.1074\/jbc.M306150200","volume":"278","author":"T Tsunenari","year":"2003","unstructured":"Tsunenari, T. et al. Structure-function analysis of the bestrophin family of anion channels. J. Biol. Chem. 278, 41114\u201341125 (2003).","journal-title":"J. Biol. Chem."},{"key":"54938_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05616-4","volume":"9","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y. et al. ATP activates bestrophin ion channels through direct interaction. Nat. Commun. 9, 3126 (2018).","journal-title":"Nat. Commun."},{"key":"54938_CR11","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41586-022-05373-x","volume":"611","author":"AP Owji","year":"2022","unstructured":"Owji, A. P. et al. Bestrophin-2 and glutamine synthetase form a complex for glutamate release. Nature 611, 180\u2013187 (2022).","journal-title":"Nature"},{"key":"54938_CR12","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1126\/science.1184334","volume":"330","author":"S Lee","year":"2010","unstructured":"Lee, S. et al. Channel-mediated tonic GABA release from glia. Science 330, 790\u2013796 (2010).","journal-title":"Science"},{"key":"54938_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cell.2012.09.005","volume":"151","author":"DH Woo","year":"2012","unstructured":"Woo, D. H. et al. TREK-1 and Best1 channels mediate fast and slow glutamate release in astrocytes upon GPCR activation. Cell 151, 25\u201340 (2012).","journal-title":"Cell"},{"key":"54938_CR14","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/nm.3639","volume":"20","author":"S Jo","year":"2014","unstructured":"Jo, S. et al. GABA from reactive astrocytes impairs memory in mouse models of Alzheimer\u2019s disease. Nat. Med. 20, 886\u2013896 (2014).","journal-title":"Nat. Med."},{"key":"54938_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/1756-6606-6-54","volume":"6","author":"H Park","year":"2013","unstructured":"Park, H. et al. High glutamate permeability and distal localization of Best1 channel in CA1 hippocampal astrocyte. Mol. Brain 6, 54 (2013).","journal-title":"Mol. Brain"},{"key":"54938_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52039-5","volume":"15","author":"J Wang","year":"2024","unstructured":"Wang, J. et al. GAD65 tunes the functions of Best1 as a GABA receptor and a neurotransmitter conducting channel. Nat. Commun. 15, 8051 (2024).","journal-title":"Nat. Commun."},{"key":"54938_CR17","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nature13913","volume":"516","author":"V Kane Dickson","year":"2014","unstructured":"Kane Dickson, V., Pedi, L. & Long, S. B. Structure and insights into the function of a Ca(2+)-activated Cl(-) channel. Nature 516, 213\u2013218 (2014).","journal-title":"Nature"},{"key":"54938_CR18","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1126\/science.1259723","volume":"346","author":"T Yang","year":"2014","unstructured":"Yang, T. et al. Structure and selectivity in bestrophin ion channels. Science 346, 355\u2013359 (2014).","journal-title":"Science"},{"key":"54938_CR19","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s42003-019-0433-3","volume":"2","author":"C Ji","year":"2019","unstructured":"Ji, C. et al. Dual Ca(2+)-dependent gates in human Bestrophin1 underlie disease-causing mechanisms of gain-of-function mutations. Commun. Biol. 2, 240 (2019).","journal-title":"Commun. Biol."},{"key":"54938_CR20","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41594-020-0402-z","volume":"27","author":"AP Owji","year":"2020","unstructured":"Owji, A. P. et al. Structural and functional characterization of the bestrophin-2 anion channel. Nat. Struct. Mol. Biol. 27, 382\u2013391 (2020).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"54938_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31437-7","volume":"13","author":"AP Owji","year":"2022","unstructured":"Owji, A. P. et al. Structures and gating mechanisms of human bestrophin anion channels. Nat. Commun. 13, 3836 (2022).","journal-title":"Nat. Commun."},{"key":"54938_CR22","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1016\/j.febslet.2006.03.025","volume":"580","author":"Z Qu","year":"2006","unstructured":"Qu, Z., Cui, Y. & Hartzell, C. A short motif in the C-terminus of mouse bestrophin 3 [corrected] inhibits its activation as a Cl channel. FEBS Lett. 580, 2141\u20132146 (2006).","journal-title":"FEBS Lett."},{"key":"54938_CR23","doi-asserted-by":"publisher","first-page":"17460","DOI":"10.1074\/jbc.M701043200","volume":"282","author":"ZQ Qu","year":"2007","unstructured":"Qu, Z. Q., Yu, K., Cui, Y. Y., Ying, C. & Hartzell, C. Activation of bestrophin Cl- channels is regulated by C-terminal domains. J. Biol. Chem. 282, 17460\u201317467 (2007).","journal-title":"J. Biol. Chem."},{"key":"54938_CR24","doi-asserted-by":"publisher","unstructured":"Kittredge, A., Ji, C., Zhang, Y. & Yang, T. Differentiation, maintenance, and analysis of human retinal pigment epithelium cells: a disease-in-a-dish model for BEST1 mutations. J. Vis. Exp. https:\/\/doi.org\/10.3791\/57791 (2018).","DOI":"10.3791\/57791"},{"key":"54938_CR25","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/bs.mie.2021.01.004","volume":"654","author":"A Kittredge","year":"2021","unstructured":"Kittredge, A., Zhang, Y. & Yang, T. Evaluating BEST1 mutations in pluripotent stem cell-derived retinal pigment epithelial cells. Methods Enzymol. 654, 365\u2013382 (2021).","journal-title":"Methods Enzymol."},{"key":"54938_CR26","doi-asserted-by":"publisher","unstructured":"Li, Y. et al. Patient-specific mutations impair BESTROPHIN1\u2019s essential role in mediating Ca2+-dependent Cl- currents in human RPE. eLife 6 https:\/\/doi.org\/10.7554\/eLife.29914 (2017).","DOI":"10.7554\/eLife.29914"},{"key":"54938_CR27","doi-asserted-by":"publisher","unstructured":"Zhao, Q. et al. Distinct expression requirements and rescue strategies for BEST1 loss- and gain-of-function mutations. eLife 10 https:\/\/doi.org\/10.7554\/eLife.67622 (2021).","DOI":"10.7554\/eLife.67622"},{"key":"54938_CR28","doi-asserted-by":"publisher","unstructured":"Gramlich, O. W., Godwin, C. R., Wadkins, D., Elwood, B. W. & Kuehn, M. H. Early functional impairment in experimental glaucoma is accompanied by disruption of the GABAergic system and inceptive neuroinflammation. Int. J. Mol. Sci. 22 https:\/\/doi.org\/10.3390\/ijms22147581 (2021).","DOI":"10.3390\/ijms22147581"},{"key":"54938_CR29","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.neuint.2007.08.014","volume":"52","author":"MC Moreno","year":"2008","unstructured":"Moreno, M. C. et al. Effect of ocular hypertension on retinal GABAergic activity. Neurochem. Int. 52, 675\u2013682 (2008).","journal-title":"Neurochem. Int."},{"key":"54938_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-54892-7","volume":"9","author":"C Ji","year":"2019","unstructured":"Ji, C. et al. Investigation and restoration of BEST1 activity in patient-derived RPEs with dominant mutations. Sci. Rep. 9, 19026 (2019).","journal-title":"Sci. Rep."},{"key":"54938_CR31","doi-asserted-by":"publisher","unstructured":"Kittredge, A., Ward, N., Hopiavuori, A., Zhang, Y. & Yang, T. Expression and purification of mammalian bestrophin ion channels. J. Vis. Exp. https:\/\/doi.org\/10.3791\/57832 (2018).","DOI":"10.3791\/57832"},{"key":"54938_CR32","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1107\/S2059798318006551","volume":"74","author":"PV Afonine","year":"2018","unstructured":"Afonine, P. V. et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr. D Struct. Biol. 74, 531\u2013544 (2018).","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"54938_CR33","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"54938_CR34","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1107\/S2059798318000979","volume":"74","author":"O Kovalevskiy","year":"2018","unstructured":"Kovalevskiy, O., Nicholls, R. A., Long, F., Carlon, A. & Murshudov, G. N. Overview of refinement procedures within REFMAC5: utilizing data from different sources. Acta Crystallogr. D. Struct. Biol. 74, 215\u2013227 (2018).","journal-title":"Acta Crystallogr. D. Struct. Biol."},{"key":"54938_CR35","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1107\/S0907444911001314","volume":"67","author":"GN Murshudov","year":"2011","unstructured":"Murshudov, G. N. et al. REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr. D. Biol. Crystallogr. 67, 355\u2013367 (2011).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"54938_CR36","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1167\/iovs.18-24213","volume":"59","author":"M Paavo","year":"2018","unstructured":"Paavo, M. et al. Mutations in GPR143\/OA1 and ABCA4 inform interpretations of short-wavelength and near-infrared fundus autofluorescence. Investig. Ophthalmol. Vis. Sci. 59, 2459\u20132469 (2018).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"54938_CR37","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/pro.3330","volume":"27","author":"CJ Williams","year":"2018","unstructured":"Williams, C. J. et al. MolProbity: more and better reference data for improved all-atom structure validation. Protein Sci. Publ. Protein Soc. 27, 293\u2013315 (2018).","journal-title":"Protein Sci. Publ. Protein Soc."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54938-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54938-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54938-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T17:04:51Z","timestamp":1735578291000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54938-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,30]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["54938"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-54938-z","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,30]]},"assertion":[{"value":"18 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Provisional Patents on glutamate (no. 63\/693,687) and GABA\/PABA (no. 63\/693,686) analogs as bestrophin activators have been filed, listing A.P.O., Y.Z., and T.Y. as inventors. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10766"}}